CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor α and estrogen receptor β expressions

Cancer Research

Volumn 63, Issue 14, 2003, Pages 3913-3918

  Sasaki, Masahiro ^a   Tanaka, Yuichiro ^a   Kaneuchi, Masanori ^a   Sakuragi, Noriaki ^b   Dahiya, Rajvir ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYTOCHROME P450 1B1; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RISK; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; DNA SEQUENCE; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0043175474     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sasaki, M., Kotcherguina, L., Dharia, A., Fujimoto, S., and Dahiya, R. Cytosinephosphoguanine methylation of estrogen receptors in endometrial cancer. Cancer Res., 61: 3262-3266, 2001.
2. Liehr, J. G. Genotoxic effects of estrogens. Mutat. Res., 238: 269-276, 1990.
3. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
4. Newbold, R. R., and Liehr, J. G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res., 60: 235-237, 2000.
5. Han, X., and Liehr, J. G. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis (Lond.), 15: 997-1000, 1994.
6. Meyer, U. A., Gut, J., Kronbach, T., Skoda, C., Meier, U. T., and Catin, T. The molecular mechanisms of two common polymorphisms of drug oxidation - evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica, 16: 449-464, 1986.
7. Kawajiri, K., Watanabe, J., Eguchi, H., and Hayashi, S. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics, 5: 70-73, 1995.
8. Hanna, I. H., Dawling, S., Roodi, N., Guengerich, F. P., and Parl, F. F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res., 60: 3440-3444, 2000.
9. Bailey, L. R., Roodi, N., Dupont, W. D., and Parl, F. F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res., 58: 5038-5041, 1998.
10. Stoilov, I., Akarsu, A. N., and Alozie, I. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet., 62: 573-584, 1998.
11. Bejjani, B. A., Lewis, R. A., Tomey, K. F., Anderson, K. L., Dueker, D. K., Jabak, M., Astle, W. F., Otterud, B., Leppert, M., and Lupski, J. R. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am. J. Hum. Genet., 62: 325-333, 1998.
12. Sasaki, M., Dharia, A., Oh, B. R., Tanaka, Y., Fujimoto, S., and Dahiya, R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res., 61: 97-102, 2001.
13. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
14. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorvic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., and Cerny, R. L. Molecular origin of cancer: catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
15. Liehr, J. G. Catecholestrogens in the induction of tumors in the kidney of the Syrian hamster. Adv. Pharmacol., 42: 824-828, 1998.
16. Jefcoate, C. R., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., Tekmal, R., Demers, L., Pauley, R., Naftolin, F., Mor, G., and Berstein, L. Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr., 2000: 95-112, 2000.
17. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., and Roy, D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J. Natl. Cancer Inst. Monogr., 2000: 75-93, 2000.
18. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56: 2979-2984, 1996.
19. Lee, K. M., Abel, J., Ko, Y., Harth, V., Park, W. Y., Seo, J. S., Yoo, K. Y., Choi, J. Y., Shin, A., Ahn, S. H., Noh, D. Y., Hirvonen, A., and Kang, D. Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br. J. Cancer, 88: 675-678, 2003.
20. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol., 46: 781-789, 1993.